[ Inside the business ]

SNPS stock analysis

SNPS · Synopsys Inc

Services-prepackaged software. Growing 42%. Keeps 9¢ of every dollar.

Nothing unusual in its latest filings.

The future, in 7 questions

Priced in: 3.3× sales in 5 yrs. Evidence: backlog of 1.2× sales · sales +42% · 9¢ profit/$1.

01 What's priced in?3.3× sales in 5 yrs
Sales now$9.4B
Needed in 5 yrs$30.6B
Backlog$10.9B
02 Is the wave rising?AI chip design tools · 0.8×
'20'21'22'23'24'2516
#2 of 20 mentioning it
03 Will customers keep buying?Sales +42%, steady
No customer over 10%
Backlog $10.9B · 1.2× salesPrepaid $2.7BSales +42%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 9¢ per $1, falling
'21'22'23'24'259¢
Before running costs: 73% → 77%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +3.3%/yrDebt $10B
07 What could break it?2 to watch
  • Fraud-pattern score high (3.6)
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +66%, +42%, then +42% vs. a year ago.

What could go wrong

Few warning signs.

It has moved 1.2× the market. In the 2008 crisis it fell 34% while the market fell 51%. Debt is heavy.

Speculative check

Not classified.

Not Self-funding because of: weak Piotroski score.

What they sell

41% License and Maintenance.

License and Maintenance 41% · Technology Service 32% · License 27%

Where each dollar goes

9¢ profit.

28¢ to make what it sells, 64¢ on research and overhead, 9¢ left over. Revenue $9.4B in the last 12 months.

Its market

2.0× the economy.

The government expects its industry, software publishers, to grow 4.0% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Some warning signs.

A few of its numbers drift toward the pattern of past manipulators. Cash covers 273¢ of each $1 of profit.

Competitive advantage

6 of 10 years.

Returns beat its 9.2% cost of capital in 6 of the last 10 years. Gross margin went from 78% to 77%.

Future bets

31% on research.

$2.9B a year on R&D. $191M on equipment and buildings.

All figures from Synopsys Inc's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.